Effect of CGS 26303, an endothelin-converting enzyme-neutral endopeptidase inhibitor, on nitrofen-induced congenital diaphragmatic hernia in the rat

Journal of Pediatric Surgery

Volumn 35, Issue 5, 2000, Pages 780-784

  Kavanagh, Mélanie ^a   Battistini, Bruno ^a   Kluth, Dietrich ^a   Jean, Sonia ^a   Fournier, Louis ^a   Jeng, Arco Y ^a   Major, Diane ^a   Cloutier, Raymond ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Congenital diaphragmatic hernia; Endothelin converting enzyme; Endothelins; Nitrofen; Prenatal

Indexed keywords

2 (4 BIPHENYLYL) 1 (1H TETRAZOL 5 YL)ETHYLAMINOMETHYLPHOSPHONIC ACID; ENDOTHELIN CONVERTING ENZYME; NITROFEN; PROTEINASE INHIBITOR;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONGENITAL DIAPHRAGM HERNIA; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; LUNG HYPOPLASIA; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; PREGNANCY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT;

EID: 0034060347     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1053/jpsu.2000.6068     Document Type: Article

References (33)

1. Langham MR, Kays DW, Ledbetter DJ, et al. Congenital diaphragmatic hernia. Epidemiology and outcome. Clin Perinatol. 23:1996;671-688
2. Puri P. Congenital diaphragmatic hernia. Curr Prob Surg. 31:1994;786-856
3. Puri P. Epidemiology of congenital diaphragmatic hernia. Mod Probl Paediatr. 24:1989;22-27
4. Thébaud B, Mercier JC, Dinh-Xuan AT. Congenital diaphragmatic hernia: A cause of persistent pulmonary hypertension of the newborn which lacks an effective therapy. Biol Neonate. 74:1998;323-336
5. Tenbrinck R, Gaillard JLJ, Tibboel D, et al. Pulmonary vascular abnormalities in experimentally induced congenital diaphragmatic hernia in rats. J Pediatr Surg. 27:1992;862-865
6. Taira Y, Yamataka T, Miyazaki E, et al. Advential changes in pulmonary vasculature in congenital diaphragmatic hernia complicated by pulmonary hypertension. J Pediatr Surg. 33:1998;382-387
7. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415
8. Uchida Y, Nimomiya H, Saotome M, et al. Endothelin, a novel vasoconstrictor peptide, as potent bronchoconstrictor. Eur J Pharmacol. 154:1988;227-228
9. Battistini B, D'Orléans-Juste P, Sirois P. Endothelins: Circulating plasma levels and presence in other biological fluids. Lab Invest. 68:1993;600-628
10. Battistini B, Botting R. Endothelins: A quantum leap forward. DN&P. 6:1995;365-391
11. Sakurai T, Yanagisawa M, Masaki T. Molecular characterisation of endothelin receptors. TiPS. 13:1992;103-108
12. Ross RD. Endothelin and pulmonary blood flow. Am Heart J. 132:1996;1317-1319
13. Battistini B, Chailler P, D'Orléans-Juste P, et al. Growth regulatory properties of endothelins. Peptides. 14:1993;385-399
14. Kobayashi H, Puri P. Plasma endothelin levels in congenital diaphragmatic hernia. J Pediatr Surg. 29:1994;1258-1261
15. Rosenberg AA, Kennaugh J, Koppenhafer SL, et al. Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension. J Pediatr. 123:1993;109-114
16. Okazaki T, Sharma HS, McKune SK, et al. Pulmonary vascular balance in congenital diaphragmatic hernia: Enhanced endothelin-1 gene expression as a possible cause of pulmonary vasoconstriction. J Pediatr Surg. 33:1998;81-84
17. Kluth D, Kangah R, Reich P, et al. Nitrofen-induced diaphragmatic hernia in rats: An animal model. J Pediatr Surg. 25:1990;850-854
18. De Lombaert S, Blanchard L, Berry C, et al. Non-peptidic inhibitors of neutral endopeptidase 24.11.2. Design and pharmacology of orally active phosphonate prodrugs. Bioorg Med Chem Lett. 5:1995;151-154
19. De Lombaert S, Stamford LB, Blanchard L, et al. Potent non-peptidic dual inhibitors of endothelin-converting enzyme and neutral endopeptidase 24.11. Bioorg Med Chem Lett. 7:1997;1059-1064
20. Pelletier S, Battistini B, Jeng AY, et al. Effects of dual endothelin-converting enzyme/neutral endopeptidase inhibitors, CGS 26303 and CGS 26393, on lipopolysaccharide or interleukin-1 (-stimulated release of endothelin from guinea pig tracheal epithelial cells. J Cardiovasc Pharm. 31:1998;S10-12
21. Trapani AJ, De Lombaert S, Kuzmich S, et al. Inhibition of big ET-1-induced pressor response by an orally active dual inhibitor of endothelin-converting enzyme and neutral endopeptidase 24.11. J Cardiovasc Pharmacol. 26:1995;S69-71
22. De Lombaert S, Ghai RD, Jeng AY, et al. Pharmacological profile of a non-peptidic dual inhibitor of neutral endopeptidase 24.11 and endothelin-converting enzyme. Biochem Bioph Res Co. 204:1994;407-412
23. Mychaliska GB, Bullard KM, Harrison MR. In utero management of congenital diaphragmatic hernia. Clin Perinatol. 23:1996;823-841
24. Davis CF, Sabharwal AJ. Management of congenital diaphragmatic hernia. Arch Dis Child Fetal Neonatal Ed. 79:1998;F1-F3
25. Tannuri U, Maksoud-Filho JG, Santos MM, et al. The effects of prenatal intraamniotic surfactant or dexamethasone administration on lung development are comparable to changes induced by tracheal ligation in an animal model of congenital diaphragmatic hernia. J Pediatr Surg. 33:1998;1198-1205
26. Goldie RG. Endothelin receptor subtypes: Distribution and function in the lung. Pulmonol Pharmacol Ther. 11:1998;89-95
27. Coppola CP, Au-Fliegner M, Gosche JR. Endothelin-1 pulmonary vasoconstriction in rats with diaphragmatic hernia. J Surg Res. 76:1998;74-78
28. Taira Y, Miyazaki E, Ohshiro K, et al. Administration of antenatal glucocorticoids prevents pulmonary artery structural changes in nitrofen-induced congenital diaphragmatic hernia in rats. J Pediatr Surg. 33:1998;1052-1056
29. Okoye BO, Losty PD, Lloyd DA, et al. Effect of prenatal glucocorticoids on pulmonary vascular muscularisation in nitrofen-induced congenital diaphragmatic hernia. J Pediatr Surg. 33:1998;76-80
30. Nambi P, Pullen M, Wu HL, et al. Dexamethasone down-regulates the expression of endothelin receptors in vascular smooth muscle cells. J Biol Chem. 25:1992;19555-19559
31. Wilcox DT, Irish MS, Holm BA, et al. Animal models in congenital diaphragmatic hernia. Clin Perinatol. 23:1996;813-822
32. Kluth D, Aalamian M, Pollock J, et al. The liver in chemically induced diaphragmatic hernia in rats. Presented at the 29th annual meeting of the Canadian Association of Paediatric Surgeon, Banff, Canada, October 4-6, 1997:
33. DiFiore JW, Wilson JM. Lung liquid, fetal lung growth, and congenital diaphragmatic hernia. Pediatr Surg Int. 10:1995;2-9